Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CARM1 | Q86X55 | 1/20 | 0.36 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.36 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.35 |
| ▸ | HTR4 | Q13639 | 5/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.34 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.33 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.33 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.33 |
| ▸ | HTR1D | P28221 | 1/20 | 0.33 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.33 |
| ▸ | HTR2B | P41595 | 1/20 | 0.33 |
| ▸ | HTR3A | P46098 | 1/20 | 0.33 |
| ▸ | JMJD6 | Q6NYC1 | 1/20 | 0.32 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | FKBP1A | P62942 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16363476 | 0.76 | LTA4H (0.35) | CARM1PRMT6SLC29A1SLC18A3JMJD6 | |
| SCHEMBL16363475 | 0.72 | LMNA (0.33) | CHRM3SMN1; SMN2 | |
| SCHEMBL10089202 | 0.70 | EPHX2 (0.36) | GAA | |
| SCHEMBL10698103 | 0.68 | ALDH1A1 (0.52) | SLC29A1SLC18A3HSD11B1 | |
| SCHEMBL13080335 | 0.67 | ALDH1A1 (0.53) | — | |
| SCHEMBL9345661 | 0.66 | CARM1 (0.42) | CARM1PRMT6HTR4CHRM4CHRM5 | |
| SCHEMBL14500265 | 0.66 | SLC29A1 (0.46) | SLC29A1SLC18A3HSD11B1SMN1; SMN2 | |
| SCHEMBL18499282 | 0.65 | ALDH1A1 (0.39) | GAASMN1; SMN2 | |
| SCHEMBL14609741 | 0.65 | SMN1; SMN2 (0.64) | SMN1; SMN2 | |
| SCHEMBL28037373 | 0.65 | HTR4 (0.42) | CARM1PRMT6HTR4SLC18A3CHRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8920793-B2 | Biodegradable PAOX polymer particle with cationic property | INDUSTRIAL COOPERATION FOUNDATION CHONBUK NATIONAL UNIVERSITY (KR) | 2014-12-30 | — | — | US | disclosed |
| US-20120288487-A1 | BIODEGRADABLE PAOX POLYMER PARTICLE WITH CATIONIC PROPERTY | INDUSTRIAL COOPERATION FOUNDATION CHONBUK NATIONAL UNIVERSITY (KR) | 2012-11-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120288487-A1 | BIODEGRADABLE PAOX POLYMER PARTICLE WITH CATIONIC PROPERTY | PAOX, PPOX, ACOX1 | CARM1 3231/4885PRMT6 4683/4885SLC29A1 2831/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.